OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 32
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1916-1916
Open Access | Times Cited: 393
Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1916-1916
Open Access | Times Cited: 393
Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 30
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 30
Ascorbic acid: a metabolite switch for designing stress-smart crops
Shefali Mishra, Ankush Sharma, Ashish Kumar Srivastava
Critical Reviews in Biotechnology (2024) Vol. 44, Iss. 7, pp. 1350-1366
Closed Access | Times Cited: 10
Shefali Mishra, Ankush Sharma, Ashish Kumar Srivastava
Critical Reviews in Biotechnology (2024) Vol. 44, Iss. 7, pp. 1350-1366
Closed Access | Times Cited: 10
Cell Membrane‐Coated Nanoparticles: A New Frontier in Immunomodulation
Nimeet Desai, Vishakha Tambe, Prasad Pofali, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 9
Nimeet Desai, Vishakha Tambe, Prasad Pofali, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 9
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 20
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 20
Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics
Sai Nikhil Uppala, Kamatham Pushpa Tryphena, Padmashri Naren, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111826-111826
Closed Access | Times Cited: 19
Sai Nikhil Uppala, Kamatham Pushpa Tryphena, Padmashri Naren, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111826-111826
Closed Access | Times Cited: 19
Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases
Siwei Chu, Xinyi Xie, Carla Payan, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15
Siwei Chu, Xinyi Xie, Carla Payan, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision
Sudipta Panja, Lubaba A. Zaman, Chen Zhang, et al.
(2025)
Closed Access
Sudipta Panja, Lubaba A. Zaman, Chen Zhang, et al.
(2025)
Closed Access
CRISPR-Cas9 Gene Editing for Targeting Cancer Stem Cells in Glioblastoma Multiforme
Saifullah Khan Mahar, Ali Amara, Ammara Ali, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 2, pp. 394-407
Closed Access
Saifullah Khan Mahar, Ali Amara, Ammara Ali, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 2, pp. 394-407
Closed Access
Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment
Asif Nawaz, Nur Aisya Affrina Mohamed Ariffin, Wong Tin Wui
Asian Journal of Pharmaceutical Sciences (2025), pp. 101041-101041
Open Access
Asif Nawaz, Nur Aisya Affrina Mohamed Ariffin, Wong Tin Wui
Asian Journal of Pharmaceutical Sciences (2025), pp. 101041-101041
Open Access
Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature
Al-Hassan Soliman Wadan, Ahmed Shaaban, Mohamed El‐Sadek, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Al-Hassan Soliman Wadan, Ahmed Shaaban, Mohamed El‐Sadek, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
Xinmei Liu, Mengyu Gao, Ji Bao
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 540-540
Open Access
Xinmei Liu, Mengyu Gao, Ji Bao
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 540-540
Open Access
Navigating the frontier: Comprehensive insights into CRISPR technology advancements, delivery strategies, and ethical considerations in cancer research
Manisha S. Jain, K. S. Srikruthi, Prakash Goudanavar, et al.
Oral Oncology Reports (2024) Vol. 9, pp. 100224-100224
Open Access | Times Cited: 3
Manisha S. Jain, K. S. Srikruthi, Prakash Goudanavar, et al.
Oral Oncology Reports (2024) Vol. 9, pp. 100224-100224
Open Access | Times Cited: 3
Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases
Lanjie Lei, Wenjie Pan, Xin Shou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Lanjie Lei, Wenjie Pan, Xin Shou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Emerging lipid–polymer hybrid nanoparticles for genome editing
Mariana Gameiro, João F. Mano, Vítor M. Gaspar
Polymer Chemistry (2024) Vol. 15, Iss. 34, pp. 3436-3468
Closed Access | Times Cited: 3
Mariana Gameiro, João F. Mano, Vítor M. Gaspar
Polymer Chemistry (2024) Vol. 15, Iss. 34, pp. 3436-3468
Closed Access | Times Cited: 3
Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson’s disease model
Paula Guzmán-Sastoque, Sebastián Sotelo, Natalia P. Esmeral, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 3
Paula Guzmán-Sastoque, Sebastián Sotelo, Natalia P. Esmeral, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 3
Reduced circulating CD63+ extracellular vesicle levels associate with atherosclerosis in hypercholesterolaemic mice and humans
Brachyahu Meir Kestecher, Krisztína Németh, S. Ghosal, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Brachyahu Meir Kestecher, Krisztína Németh, S. Ghosal, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Delineating Effect of Headgroup and Preparation Method on Transfection Versus Toxicity of DNA-Loaded Lipid Nanocarriers
Aishwarya Saraswat, Ketan Patel
Nanomedicine (2023) Vol. 18, Iss. 26, pp. 1921-1940
Closed Access | Times Cited: 7
Aishwarya Saraswat, Ketan Patel
Nanomedicine (2023) Vol. 18, Iss. 26, pp. 1921-1940
Closed Access | Times Cited: 7
Functional Genomics and Network Biology
Amit Joshi, Ajay Kumar, Vikas Kaushik
Advances in Bioinformatics (2024), pp. 71-96
Closed Access | Times Cited: 2
Amit Joshi, Ajay Kumar, Vikas Kaushik
Advances in Bioinformatics (2024), pp. 71-96
Closed Access | Times Cited: 2
CRISPR-Cas9 Genome Editing Technology for Zoonotic Disease Control in Indonesia: A Comprehensive Review
I Made Dwi Mertha Adnyana, Dwinka Syafira Eljatin, Ni Luh Gede Sudaryati, et al.
Journal of Medicine and Health Technology (2024) Vol. 1, Iss. 1, pp. 21-39
Open Access | Times Cited: 1
I Made Dwi Mertha Adnyana, Dwinka Syafira Eljatin, Ni Luh Gede Sudaryati, et al.
Journal of Medicine and Health Technology (2024) Vol. 1, Iss. 1, pp. 21-39
Open Access | Times Cited: 1
Enhancement of MCF-7 and HeLa Cell Interfacial Interactions using Pulse Electric Field and Natural Sustainable Resources
Suhassni Ganeson, Muhammad Mahadi Abdul Jamil, Radzi Ambar, et al.
Procedia Computer Science (2024) Vol. 236, pp. 289-297
Open Access | Times Cited: 1
Suhassni Ganeson, Muhammad Mahadi Abdul Jamil, Radzi Ambar, et al.
Procedia Computer Science (2024) Vol. 236, pp. 289-297
Open Access | Times Cited: 1
Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment
Ling-Wu Tong, Yongshan Hu, Shi-Jing Yu, et al.
Nanotechnology (2024) Vol. 35, Iss. 40, pp. 402002-402002
Closed Access | Times Cited: 1
Ling-Wu Tong, Yongshan Hu, Shi-Jing Yu, et al.
Nanotechnology (2024) Vol. 35, Iss. 40, pp. 402002-402002
Closed Access | Times Cited: 1
Emerging Gene-editing nano-therapeutics for Cancer
Najma Nujoom, Manzoor Koyakutty, Lalitha Biswas, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39323-e39323
Open Access | Times Cited: 1
Najma Nujoom, Manzoor Koyakutty, Lalitha Biswas, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39323-e39323
Open Access | Times Cited: 1
From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications
Timur Saliev, Prim B. Singh
Cells (2024) Vol. 13, Iss. 24, pp. 2052-2052
Open Access | Times Cited: 1
Timur Saliev, Prim B. Singh
Cells (2024) Vol. 13, Iss. 24, pp. 2052-2052
Open Access | Times Cited: 1
